- €1.13bn
- €965.49m
- €741.18m
- 99
- 30
- 85
- 86
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 21.23 | ||
| PEG Ratio (f) | 4.67 | ||
| EPS Growth (f) | 4.76% | ||
| Dividend Yield (f) | 3% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.24 | ||
| Price to Tang. Book | 3.85 | ||
| Price to Free Cashflow | 26.42 | ||
| Price to Sales | 1.46 | ||
| EV to EBITDA | 10.71 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 16.85% | ||
| Return on Equity | 14.25% | ||
| Operating Margin | 9.48% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 510.07 | 524.49 | 579.88 | 665.38 | 741.17 | 801 | 841.4 | 8.63% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +7.31 | +11.43 | +22.22 | +15.72 | +10.86 | +5.13 | +4.76 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Neurones SA is a France-based company, which provides information technology (IT) services. It operates within three areas: consulting, integration of technological solutions and outsourcing of information systems. The business lines are organized into three centers: Infrastructures Business, Consulting Business and Applications Business. Within the Infrastructures area, the Company provides design, integration and operation of system and networks, service desk, production engineering services, as well as remote servers and application operations and asset management consulting. As per the Applications business line, Neurones SA offers analysis, expertise and software development as well as support and third-party application maintenance. Consulting business line provides development, maintenance of applications, trainings, among others. The Company operates through several subsidiaries, including Axones SAS, Arondor, AS Delivery, AS International and Edugroupe.
Directors
- Luc De Chammard CHM (67)
- Bertrand Ducurtil EVP (61)
- Paul Bonnel DRC
- Daphne de Chammard DRC (72)
- Herve Pichard DRC (66)
- Marie-Francoise Jaubert IND (79)
- Jean-Louis Pacquement IND (66)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- January 15th, 1985
- Public Since
- May 23rd, 2000
- No. of Employees
- 6,849
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
Euronext - Paris- Shares in Issue
- 24,278,716
- Address
- Nanterre Cedex, NANTERRE, 92024
- Web
- https://www.neurones.net
- Phone
- +33 141374137
- Contact
- Paul Bonnel
- Auditors
- KPMG S.A.
Upcoming Events for NRO
Neurones SA Annual Shareholders Meeting
Neurones SA Annual Shareholders Meeting
Q2 2025 Neurones SA Corporate Sales Release
Half Year 2025 Neurones SA Earnings Release
Similar to NRO
74Software SA
Euronext - Paris
Acteos SA
Euronext - Paris
Alten SA
Euronext - Paris
Atos SE
Euronext - Paris
Aubay SA
Euronext - Paris
FAQ
What is the Neurones SA share price?
As of Today at 04:13 UTC, shares in Neurones SA are trading at €46.70. This share price information is delayed by 15 minutes.
How has the Neurones SA share price performed this year?
Shares in Neurones SA last closed at €46.70 and the price had moved by +4.01% over the past 365 days. In terms of relative price strength the Neurones SA share price has outperformed the FTSE Global All Cap Index by +1.41% over the past year.
What are the analyst and broker recommendations for Neurones SA?
The overall consensus recommendation for Neurones SA is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Neurones SA dividend yield?
The Neurones SA dividend yield is 2.57% based on the trailing twelve month period.
Does Neurones SA pay a dividend?
Last year, Neurones SA paid a total dividend of €1.20, and it currently has a trailing dividend yield of 2.57%. We do not have any data on when Neurones SA is to next pay dividends.
When does Neurones SA next pay dividends?
We do not have data on when Neurones SA is to next pay dividends. The historic dividend yield on Neurones SA shares is currently 2.57%.
How do I buy Neurones SA shares?
To buy shares in Neurones SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Neurones SA?
As of the previous close price of €46.70, shares in Neurones SA had a market capitalisation of €1.13bn.
Where are Neurones SA shares listed?
Here are the trading details for Neurones SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: NRO
What kind of share is Neurones SA?
Based on an overall assessment of its quality, value and momentum Neurones SA is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Neurones SA share price forecast for 2025?
The analyst consensus target price for shares in Neurones SA is €60.00. That is 28.48% above the last closing price of €46.70.
Analysts covering Neurones SA currently have a consensus Earnings Per Share (EPS) forecast of €2.10 for the next financial year.
Find out moreWhat is the trend in the Neurones SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Neurones SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -1.29%.
As of the last closing price of €46.70, shares in Neurones SA were trading +3.72% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Neurones SA PE Ratio?
The Neurones SA PE ratio based on its reported earnings over the past 12 months is 21.23. The shares last closed at €46.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Neurones SA?
Neurones SA's management team is headed by:
- Luc De Chammard - CHM
- Bertrand Ducurtil - EVP
- Paul Bonnel - DRC
- Daphne de Chammard - DRC
- Herve Pichard - DRC
- Marie-Francoise Jaubert - IND
- Jean-Louis Pacquement - IND